The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Head-to-head comparison between decipher and prolaris tests: Two commercially available post-prostatectomy genomic tests.
 
Mohammed Shahait
No Relationships to Disclose
 
Mohammed Alshalalfa
No Relationships to Disclose
 
Edward M. Schaeffer
Consulting or Advisory Role - Abbvie; OPKO Diagnostics
 
Huei-Chung Huang
Employment - Decipher Biosciences
 
Andrea Cronican
Employment - GenomeDx
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring
 
Ayah el-Fahmawi
No Relationships to Disclose
 
Priti Lal
No Relationships to Disclose
 
Elai Davicioni
Employment - Decipher Biosciences; GenomeDx
Leadership - Decipher Biosciences; GenomeDx
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
David I. Lee
No Relationships to Disclose